The Essential Protein & Antibody Engineering Event
The PEGS Boston Summit—short for the Protein & Antibody Engineering Summit—is recognized as the world’s leading event for biologics and protein engineering, drawing experts, innovators, and industry leaders from across the globe. For over 20 years, the conference has served as the premier gathering for professionals focused on drug development, protein and antibody engineering, immunotherapy, radiotherapy, and AI/ML-driven biologics research.
Key 2026 Event Details
The 2026 edition of the PEGS Boston Summit was held from May 11–15, 2026, at the Omni Boston Hotel at the Seaport in Boston, Massachusetts. This marked a shift from the venue used for previous editions.
The summit brought together over 2,000 industry experts, featuring more than 350 presentations from leading researchers and thought leaders. Its comprehensive program covered 21 conference tracks and training seminars, delving into topics such as bispecific antibody development, protein expression platforms, bioanalytics, and computational modeling.
2026 Keynote Highlights
The 2026 event featured a distinguished lineup of keynote speakers, including:
- Plenary Keynote: Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center, who delivered a talk titled “CARs 2026: New Models and New Runways.”
- Young Scientist Keynote: Martin Pacesa, PhD, Assistant Professor at the University of Zurich, on “Deep Learning-based Binder Design to Probe Biology.”
- Plenary Fireside Chat: A discussion on designing smart biologics in the age of GenAI, moderated by Christopher Langmead, PhD of Danaher Corporation, featuring panelists from Nabla Bio, AstraZeneca, Chai Discovery, and Sanofi.
2026 New Focus: Peptide Therapeutics
A notable addition to the 2026 program was a dedicated focus on the therapeutic power of peptides, highlighting their design innovations and expanding role in drug discovery. This was integrated into the “Emerging Therapeutics Stream,” which also covered biologics for autoimmune diseases and frontiers in radiopharmaceutical therapies.
Industry Participation
The event saw significant participation from the biopharma sector. Notable industry players like Biocytogen attended to gain insights, while others such as Ajinomoto Bio-Pharma Services utilized the summit to deliver oral presentations and showcase posters on their innovations, including new manufacturing platforms and conjugation technologies.
Looking Ahead: PEGS Boston 2027
The PEGS Boston Summit has already announced its return for 2027. The next edition is scheduled to take place from May 10–14, 2027, once again at the Omni Boston Hotel at the Seaport in Boston. The 2027 event is expected to continue the tradition of providing unparalleled insights into the future of biologics and protein engineering.